Apellis Pharmactdl 0001 Stock Price To Earning
| 1JK Stock | EUR 31.28 0.82 2.55% |
APELLIS PHARMACTDL 0001 fundamentals help investors to digest information that contributes to APELLIS PHARMACTDL's financial success or failures. It also enables traders to predict the movement of APELLIS Stock. The fundamental analysis module provides a way to measure APELLIS PHARMACTDL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to APELLIS PHARMACTDL stock.
APELLIS |
APELLIS PHARMACTDL 0001 Company Price To Earning Analysis
APELLIS PHARMACTDL's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, APELLIS PHARMACTDL 0001 has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The price to earning for all Germany stocks is 100.0% higher than that of the company.
APELLIS Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses APELLIS PHARMACTDL's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of APELLIS PHARMACTDL could also be used in its relative valuation, which is a method of valuing APELLIS PHARMACTDL by comparing valuation metrics of similar companies.APELLIS PHARMACTDL is currently under evaluation in price to earning category among its peers.
APELLIS Fundamentals
| Return On Equity | -5.07 | |||
| Return On Asset | -0.46 | |||
| Operating Margin | (4.60) % | |||
| Shares Outstanding | 110.58 M | |||
| Shares Owned By Insiders | 15.32 % | |||
| Shares Owned By Institutions | 89.16 % | |||
| Revenue | 113.05 M | |||
| Gross Profit | (253.92 M) | |||
| EBITDA | (518.43 M) | |||
| Net Income | (460.28 M) | |||
| Cash And Equivalents | 599.01 M | |||
| Cash Per Share | 6.89 X | |||
| Total Debt | 409.63 M | |||
| Debt To Equity | 7.94 % | |||
| Current Ratio | 4.15 X | |||
| Book Value Per Share | 2.78 X | |||
| Cash Flow From Operations | (239.85 M) | |||
| Earnings Per Share | (7.48) X | |||
| Target Price | 67.81 | |||
| Number Of Employees | 767 | |||
| Beta | 1.23 | |||
| Market Capitalization | 5.78 B | |||
| Z Score | 8.4 |
About APELLIS PHARMACTDL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze APELLIS PHARMACTDL 0001's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of APELLIS PHARMACTDL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of APELLIS PHARMACTDL 0001 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in APELLIS Stock
APELLIS PHARMACTDL financial ratios help investors to determine whether APELLIS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in APELLIS with respect to the benefits of owning APELLIS PHARMACTDL security.